September 3rd 2024
We are proud to announce the appointment of Stephane Argivier as our new Chief Executive Officer, effective from 1st September 2024. Stephane Argivier will lead the next stage in the company’s expansion.
)
April 18th 2024
Sexually Transmitted Infections (STIs) continue to be a significant global health concern, affecting millions of people each year, irrespective of geographical location or economic status. While the spotlight often falls on diseases like HIV and syphilis due to their severe consequences and historical significance, other STIs such as chlamydia, gonorrhoea, and human papillomavirus (HPV) also pose substantial threats to public health worldwide.
)
December 6th 2023
Calprotectin is a heterodimer protein expressed by leucocytes and used as a biomarker for Inflammatory Bowel Disease (IBD).
){kind=icon}
March 30th 2023
Sexually transmitted infection (STI) cases across the world are an ever present and ever-increasing issue, not only to adults but to a foetus. Two diseases of particular importance are HIV and Syphilis (caused by the bacterium Treponema pallidum).
)
February 1st 2023
The flu season is well and truly upon us, but is it Influenza, RSV or Covid? And does it matter?
)
April 20th 2021
Global vaccine roll out is making progress but with most countries wanting priority status and with a limited supply, how can governments best prioritise those requiring vaccination?
)
February 1st 2021
As the pandemic has struck the predicted second wave, public struggles persist with lifestyle restrictions, but our knowledge to identify and fight the virus has significantly progressed. At present testing generally consists of Polymerase Chain Reaction (PCR ) or Lateral Flow Tests (LFT) also known as rapid or antigen tests.
)
January 11th 2021
From the outset of the COVID-19 outbreak, testing for SARS-CoV-2 has been a priority. Initially just having a test for COVID-19 was a scientific success, enabled by the publication of the first viral genomic sequence in January 2020. Here we highlight some of the key testing events that have taken place, and their outcomes.
)
October 26th 2020
At the outset of the 2019 SARS-CoV-2 / COVID-19 epidemic, diagnostic immunoassay manufacturers focused on developing anti-SARS-CoV-2 IgM & IgG tests.
)
August 5th 2020
Two types of tests for SARS-CoV-2 currently predominate. The first are molecular tests, based on PCR technology, that detect the presence of viral nucleic acid and therefore indicate a current infection. The second are serology tests.
)